Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer

NCT02560051 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped Slow accrual; resource re-allocation

Conditions

Prostatic Neoplasms

Interventions

DRUG: Doxorubicin
DRUG: Ketoconazole
DRUG: Docetaxel
DRUG: Estramustine
DRUG: Degarelix

Sponsor

The University of Texas Health Science Center, Houston